Booster Shots Finally Make It Through FDA Approval

UNITED STATES - NOVEMBER 9 - The outside of the Food and Drug Administration headquarters is seen in White Oak, Md., on Monday, November 9, 2015. The FDA is a federal agency of the United States Department of Health and Human Services and has been in commission since 1906. (Photo By Al Drago/CQ Roll Call)

After a fairly quick vetting process, the Food and Drug Administration (FDA) has finally authorized COVID-19 booster shots for use on a select group of Americans. Those people in question, people who are either elderly or at severe risk of harm from COVID-19, should be available to take the vaccine booster starting just six months after they have gotten their fully vaccinated status.

Put forth in an announcement late this past Wednesday, the booster authorization only seems to apply to Americans who have taken the Pfizer vaccine and pops up after an independent FDA panel harshly rejected any plans to recommend a generalized blanket booster policy, with zero regards to age.

“Today’s action demonstrates that science and the currently available data continue to guide the FDA’s decision-making for COVID-19 vaccines during this pandemic. After considering the totality of the available scientific evidence and the deliberations of our advisory committee of independent, external experts, the FDA amended the EUA for the Pfizer-BioNTech COVID-19 Vaccine to allow for a booster dose in certain populations such as health care workers, teachers and day care staff, grocery workers and those in homeless shelters or prisons, among others,” stated Dr. Janet Woodcock, the Acting FDA Commissioner.

“This pandemic is dynamic and evolving, with new data about vaccine safety and effectiveness becoming available every day. As we learn more about the safety and effectiveness of COVID-19 vaccines, including the use of a booster dose, we will continue to evaluate the rapidly changing science and keep the public informed,” continued the doctor.

The new authorization also seemingly applies to “individuals 18 through 64 years of age whose frequent institutional or occupational exposure to SARS-CoV-2 puts them at high risk of serious complications of COVID-19 including severe COVID-19.”

This decision coming out from the FDA crops up after an FDA independent advisory panel put forth an announcement this past week that it would not look into the booster policy that was debuted by Old Uncle Joe this past month. Biden, who mode note that the whole plan would hinge on FDA authorization, thought the boosters could be put out as available to the general public as soon as September 20th.

“The plan is for every adult to get a booster shot eight months after you got your second shot,” stated Biden back on the 18th of August, reported The New York Times. Biden went on to add, “It will make you safer, and for longer. And it will help us end the pandemic faster.”

Old Uncle Joe’s plan hit a bump in the road when there was entirely insufficient data for the Moderna and Johnson & Johnson vaccine booster shot decision stated an official to the New York Times. Seeing the issues before it cropped up, two top health officials, including Woodcock, told the White House that the plan was talked about would not be possible.

You Might Like